These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34228147)

  • 1. Novel germline mutation KMT2A G3131S confers genetic susceptibility to familial myeloproliferative neoplasms.
    Yin L; Xie S; Chen Y; Li W; Jiang X; Li H; Li J; Wu Z; Xiao X; Zhang G; Cheng Z; Peng H
    Ann Hematol; 2021 Sep; 100(9):2229-2240. PubMed ID: 34228147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia.
    Zhang H; Xiang B; Chen H; Chen X; Cai T
    BMC Med Genet; 2019 Mar; 20(1):38. PubMed ID: 30841869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering a Genetic Diagnosis in a Pediatric Patient by Whole Exome Sequencing: A Modeling Investigation in Wiedemann-Steiner Syndrome.
    di Bari I; Ceccarini C; Curcetti M; Cesarano C; Croce AI; Adipietro I; Gallicchio MG; Palladino GP; Patrizio MP; Frisoli B; Santacroce R; D'Apolito M; D'Andrea G; Castriota OM; Pierri CL; Margaglione M
    Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336746
    [No Abstract]   [Full Text] [Related]  

  • 4. Three de novo variants in KMT2A (MLL) identified by whole exome sequencing in patients with Wiedemann-Steiner syndrome.
    Luo S; Bi B; Zhang W; Zhou R; Chen W; Zhao P; Huang Y; Yuan L; He X
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1798. PubMed ID: 34469078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.
    Olcaydu D; Rumi E; Harutyunyan A; Passamonti F; Pietra D; Pascutto C; Berg T; Jäger R; Hammond E; Cazzola M; Kralovics R
    Haematologica; 2011 Mar; 96(3):367-74. PubMed ID: 21173100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
    Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
    Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.
    Jiang Y; Sun Y; Hu J; Yu N; Liu H; Fan J; Ning X; Li Y; Liu B; Sun Y; Zhang J; Qiu X; Fu S; Zhou C; Xu H
    BMC Cancer; 2019 Jun; 19(1):613. PubMed ID: 31226964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
    Rumi E; Cazzola M
    Br J Haematol; 2017 Sep; 178(5):689-698. PubMed ID: 28444727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms.
    Braunstein EM; Imada E; Pasca S; Wang S; Chen H; Alba C; Hupalo DN; Wilkerson M; Dalgard CL; Ghannam J; Liu Y; Marchionni L; Moliterno A; Hourigan CS; Gondek LP
    Leukemia; 2023 Mar; 37(3):627-635. PubMed ID: 36543879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Application of Targeted RNA Sequencing for KMT2A-Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia.
    Dai B; Yu H; Ma T; Lei Y; Wang J; Zhang Y; Lu J; Yan H; Jiang L; Chen B
    J Mol Diagn; 2021 Nov; 23(11):1478-1490. PubMed ID: 34384895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and Epigenetic Characterization of a Discordant
    Russo A; Viberti C; Mareschi K; Casalone E; Guarrera S; Birolo G; Cazzaniga G; Corral L; Trentin L; Basso G; Fagioli F; Matullo G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement.
    Taniguchi R; Muramatsu H; Okuno Y; Suzuki K; Obu S; Nakatochi M; Shimamura T; Takahashi Y; Horikoshi Y; Watanabe K; Kojima S
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trio-WES reveals a novel de novo missense mutation of KMT2A in a Chinese patient with Wiedemann-Steiner syndrome: A case report.
    Wang X; Zhang G; Lu Y; Luo X; Wu W
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1533. PubMed ID: 33325147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk.
    Chen Y; Zhang Y; Wang Z; Wang Y; Luo Y; Sun N; Zheng S; Yan W; Xiao X; Liu S; Li J; Peng H; Xu Y; Hu G; Cheng Z; Zhang G
    Cell Death Dis; 2022 Jul; 13(7):586. PubMed ID: 35798703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia.
    Hyrenius-Wittsten A; Pilheden M; Sturesson H; Hansson J; Walsh MP; Song G; Kazi JU; Liu J; Ramakrishan R; Garcia-Ruiz C; Nance S; Gupta P; Zhang J; Rönnstrand L; Hultquist A; Downing JR; Lindkvist-Petersson K; Paulsson K; Järås M; Gruber TA; Ma J; Hagström-Andersson AK
    Nat Commun; 2018 May; 9(1):1770. PubMed ID: 29720585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients.
    Li N; Wang Y; Yang Y; Wang P; Huang H; Xiong S; Sun L; Cheng M; Song C; Cheng X; Ding Y; Chang G; Chen Y; Xu Y; Yu T; Yao RE; Shen Y; Wang X; Wang J
    Orphanet J Rare Dis; 2018 Oct; 13(1):178. PubMed ID: 30305169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the phenotype associated to KMT2A variants: overlapping clinical signs between Wiedemann-Steiner and Rubinstein-Taybi syndromes.
    Di Fede E; Massa V; Augello B; Squeo G; Scarano E; Perri AM; Fischetto R; Causio FA; Zampino G; Piccione M; Curridori E; Mazza T; Castellana S; Larizza L; Ghelma F; Colombo EA; Gandini MC; Castori M; Merla G; Milani D; Gervasini C
    Eur J Hum Genet; 2021 Jan; 29(1):88-98. PubMed ID: 32641752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Wiedemann-Steiner syndrome due to novel nonsense variant of KMT2A gene in a case].
    Xue H; Feng Y; Zhang C; Ma L; Wu J; Li Q; Gao T; Cao Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Feb; 38(2):138-140. PubMed ID: 33565066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A de novo Mutation in KMT2A (MLL) in monozygotic twins with Wiedemann-Steiner syndrome.
    Dunkerton S; Field M; Cho V; Bertram E; Whittle B; Groves A; Goel H
    Am J Med Genet A; 2015 Sep; 167A(9):2182-7. PubMed ID: 25929198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An enhancer RNA recruits KMT2A to regulate transcription of Myb.
    Kim J; Diaz LF; Miller MJ; Leadem B; Krivega I; Dean A
    Cell Rep; 2024 Jul; 43(7):114378. PubMed ID: 38889007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.